← Back to All US Stocks

EMR Stock Analysis - EMERSON ELECTRIC CO AI Rating

EMR NYSE Electronic & Other Electrical Equipment (No Computer Equip) MO CIK: 0000032604
Analysis Date: Mar 19, 2026 | Data as of: 2025-12-31
AI Rating
SELL
85% Confidence

Investment Thesis

Emerson Electric exhibits severe data integrity issues with a 219% gross margin that is mathematically impossible, suggesting widespread financial reporting errors or data compilation failures. The combination of concerning liquidity metrics (0.84x current ratio, 0.62x quick ratio), weak return metrics (3.0% ROE, 1.4% ROA), and modest revenue growth of 3.0% YoY raises fundamental questions about operational efficiency and financial health that cannot be reliably assessed given the data quality problems.

EMR Strengths

  • + Positive free cash flow generation of $602M with 13.9% FCF margin demonstrates underlying cash generation capability
  • + Manageable leverage with 0.37x debt-to-equity ratio and adequate interest coverage of 5.3x
  • + Operating margin of 17.8% on reported basis shows reasonable operational efficiency despite data anomalies

EMR Risks

  • ! Critical data integrity issue: 219% gross margin is mathematically impossible (gross profit exceeds revenue), indicating fundamental reporting errors
  • ! Severely deficient liquidity with current ratio of 0.84x and quick ratio of 0.62x both below 1.0x, suggesting near-term cash management concerns
  • ! Weak capital efficiency evidenced by ROE of 3.0% and ROA of 1.4%, indicating poor returns on shareholder capital and assets despite significant asset base of $41.9B

Key Metrics to Watch

EMR Financial Metrics

Revenue
$4.3B
Net Income
$605.0M
EPS (Diluted)
$1.07
Free Cash Flow
$602.0M
Total Assets
$41.9B
Cash Position
$1.7B

EMR Profitability Ratios

Gross Margin 219.0%
Operating Margin 17.8%
Net Margin 13.9%
ROE 3.0%
ROA 1.4%
FCF Margin 13.9%

EMR Balance Sheet & Liquidity

Current Ratio
0.84x
Quick Ratio
0.62x
Debt/Equity
0.37x
Debt/Assets
0.0%
Interest Coverage
5.27x
Long-term Debt
$7.6B

EMR 5-Year Financial Trend

EMR 5-year financial data: Year 2021: Revenue $18.4B, Net Income $2.3B, EPS $3.71. Year 2022: Revenue $19.6B, Net Income $2.0B, EPS $3.24. Year 2023: Revenue $15.2B, Net Income $2.3B, EPS $3.82. Year 2024: Revenue $17.5B, Net Income $3.2B, EPS $5.41. Year 2025: Revenue $18.0B, Net Income $13.2B, EPS $22.88.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: EMERSON ELECTRIC CO's revenue has remained relatively flat over the 5-year period, with a 2% decline. The most recent EPS of $22.88 reflects profitable operations.

EMR Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
13.9%
Free cash flow / Revenue

EMR Quarterly Performance

Quarterly financial performance data for EMERSON ELECTRIC CO including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q1 2026 $4.2B $585.0M $1.02
Q3 2025 $4.4B $329.0M $0.57
Q2 2025 $4.4B $485.0M $0.86
Q1 2025 $4.1B $142.0M $0.25
Q3 2024 $3.9B $329.0M $0.57
Q2 2024 $3.8B $501.0M $0.87
Q1 2024 $3.4B $142.0M $0.25
Q3 2023 $3.5B $921.0M $1.54

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

EMR Capital Allocation

Operating Cash Flow
$699.0M
Cash generated from operations
Stock Buybacks
$250.0M
Shares repurchased (TTM)
Capital Expenditures
$97.0M
Investment in assets
Dividends Paid
$312.0M
Returned to shareholders

EMR SEC Filings

Access official SEC EDGAR filings for EMERSON ELECTRIC CO (CIK: 0000032604)

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 19, 2026 | Data as of: 2025-12-31 | Powered by Claude AI